Form 4: USANA Health Sciences Director John Turman Fleming Reports Stock Transactions

Director John Turman Fleming of USANA Health Sciences reports the vesting and disposal of restricted stock units.

Summary

• On November 2, 2024, John Turman Fleming, a director of USANA Health Sciences, reported transactions involving restricted stock units.
• 675 restricted stock units vested and were subsequently converted into common stock.
• Fleming disposed of 675 shares of common stock.
• Following these transactions, Fleming directly owns 3,852 shares of common stock and 1,348 restricted stock units.
• The restricted stock units vest in four equal installments on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.

Sentiment

Score: 5

Explanation: This is a neutral reporting of stock transactions by a company director, with no inherent positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It's a standard practice for directors and officers to receive and trade company stock as part of their compensation.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they represent a small portion of the company's outstanding shares.

Key Dates